Published May 6, 2021, 11:56 AM The Department of Science and Technology (DOST) has announced that the team tasked to look into the efficacy and safety of Laguna tablets or syrup as a coronavirus disease (COVID-19) therapeutic or supplement is set to conduct its data analysis for its placebo-controlled clinical trial next week. Lagundi (Manila Bulletin File Photo) During President Duterte’s televised public briefing on Wednesday night, May 5, DOST Secretary Fortunato “Boy” T. de la Peña said the two-stage, randomized and placebo-controlled lagundi clinical trial is expected to be completed soon. He said the overall aim of the 10 month-long project is to evaluate the efficacy and safety of Laguna tablet/syrup in patients without co-morbidities suspected or with confirmed mild COVID-19.